KRT8P35

Across TCGA pan-cancer cohorts, KRT8P35 RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated KRT8P35 data layer.

The strongest signal is observed in lymphoid neoplasm diffuse large b-cell lymphoma (DLBC), where higher KRT8P35 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated KRT8P35 expression acts as an unfavorable survival marker, although some lineages such as KIRC and PRAD show a favorable association.

DLBC, MESO, and KIRP are the cancer types where KRT8P35 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
DLBC	OS	Tertile	III,IV	0.175	0.874	.025	36	view →
MESO	OS	Tertile	III,IV	0.452	0.702	.007	25	view →
KIRP	DFS	Median	II,III,IV	0.633	0.878	.002	21	view →
KIRC	DFS	Quartile	III,IV	0.685	0.361	.015	18	view →
PRAD	DFS	Median	All	0.918	0.850	.014	18	view →
CESC	OS	Median	II,III,IV	0.847	0.669	.017	14	view →
CHOL	OS	Quartile	III,IV	0.136	0.829	.008	12	view →
STAD	DFS	Median	IV	0.204	0.571	.014	12	view →
PAAD	DFS	Median	All	0.211	0.363	.016	12	view →
LIHC	OS	Tertile	III,IV	0.291	0.675	.019	9	view →
COAD	OS	Median	All	0.485	0.785	.009	8	view →
ESCA	OS	Tertile	All	0.590	1.000	.039	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

KRT8P35–DLBC (OS)

Open the DLBC breakdown →